Influence of pertussis toxine on local progression and metastasis after orthotopic implantation of the human prostate cancer cell line PC3 in nude mice

Prostate Cancer and Prostatic Diseases

Volumn 2, Issue 1, 1999, Pages 36-40

  Bex, A ^a   Lummen G ^a   Rembrink, K ^a   Otto, T ^a   Metz, K ^a   Rubben H ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Antimotility factor; Experimental animal; Metastasis; Prostate cancer

Indexed keywords

PERTUSSIS TOXIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CELL MIGRATION; CELL MOTILITY; HORMONAL THERAPY; IMPLANTATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 2442720666     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500286     Document Type: Article

References (22)

1. Boring CC, Squires TS, Tong T. Cancer statistics. CA Cancer J Clin 1994; 44: 7-26.
2. Eisenberger MA et al. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N. Engl. J. Med. 1998; 339: 1036-1042.
3. Klocker H et al. Androgen receptor alterations in prostatic carcinoma. Prostate 1994; 25: 266-273.
4. Chung LWK et al. Human prostate cancer model: Roles of growth factors and extracellular matrices. J Cell Biochem 1992; Suppl. 16H: 99-105.
5. Jarrard DF et al. Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion. Prostate 1994; 24: 46-53
6. Connolly JM, Rose DP. Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate 1989; 15: 177-186.
7. Siegal JA, Yu E, Brawer MK. Topography of neovascularity in human prostatic carcinoma. Cancer 1995; 75: 2545-2551.
8. Umbas R et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992; 52: 5104-5109.
9. Stryer L, Bourne HR. G Proteins: a family of signal transducers. Annu Rev Cell Biol 1986; 2: 391-419.
10. Lümmen G et al. Identification of G protein-coupled receptors potently stimulating migration of human transitional-cell carcinoma cells. Naunyn-Schmiedebergs Arch Pharmacol 1997; 356: 769-776.
11. Moolenaar WH, Kranenburg O., Postma FR, Zondag GCM. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol 1997; 9: 168-173.
12. Rembrink K et al. Orthotopic implantation of human prostate cancer cell lines: A clinically relevant animal model for prostate cancer. Prostate 1997; 31: 168-174.
13. Kaighn ME et all. Establishment of a new prostatic carcinoma cell line (PC-3). Invest Urol 1979; 17: 16-23.
14. Stossel TP. On the crawling of animal cells. Science 1993; 260: 1086-1094.
15. Liotta LA et al. Tumor cell motility. Semin Cancer Biol 1991; 2: 111-114.
16. Roos E, Van de Pavert IV. Inhibition of lymphoma invasion and liver metastasis formation by pertussis toxin. Cancer Res 1987; 47: 5439-5444.
17. Otto T et al. Tumor cell motility-a novel therapeutic target in bladder cancer. J Urol 1995; 153 (Suppl): S1173.
18. Otto T et al. Paclitaxel-based second line chemotherapy for patients with advanced chemotherapy-resistant bladder carcinoma (M1). Cancer 1997 80: 465-470.
19. Ware JL, Paulson DF, Mickey GH, Webbs KS. Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. J Urol 1982; 128: 1064-1067.
20. Bex A et al. Isolation einer Zellinie DU 145 MN1 nach orthotoper Implantation von DU 145 Zellen in die Prostata der Nacktmaus. Akt Urol 1998; 28: 43.
21. Stephenson RA et al. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992; 84: 951-957.
22. Chen Q et al. Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells. J Cell Physiol 1998; 174: 261-272.